Immunome Inc. Human Resources Contracts & Agreements
33 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Compensation Agreements (4)
- Consulting Agreements (2)
- Employment Agreements (17)
- Separation Agreements (4)
- Employment Offer dated April 26, 2021, by and between the Registrant and Bob Lapetina (Filed With SEC on March 28, 2024)
- Separation Agreement effective October 3, 2023, by and between the Registrant and Purnanand D. Sarma, Ph.D (Filed With SEC on March 28, 2024)
- Consulting Agreement dated October 2, 2023, by and between the Registrant and Dennis Giesing (Filed With SEC on March 28, 2024)
- Separation Agreement effective October 2, 2023, by and between the Registrant and Dennis Giesing (Filed With SEC on March 28, 2024)
- Employment Offer Letter dated February 7, 2024, by and between the Registrant and Kinney Horn (Filed With SEC on March 28, 2024)
- Employment Offer dated November 30, 2023, by and between the Registrant and Philip Roberts (Filed With SEC on March 28, 2024)
- Amended and Restated Employment Offer Terms dated November 30, 2023, by and between the Registrant and Robert Lechleider, M.D (Filed With SEC on March 28, 2024)
- Amended and Restated Employment Offer Terms dated November 30, 2023, by and between the Registrant and Jack Higgins, Ph.D (Filed With SEC on March 28, 2024)
- Amended and Restated Employment Offer Terms dated November 30, 2023, by and between the Registrant and Max Rosett (Filed With SEC on March 28, 2024)
- Amended and Restated Employment Offer Terms dated December 21, 2023, by and between the Registrant and Bruce Turner, M.D., Ph.D (Filed With SEC on March 28, 2024)
- Amended and Restated Employment Offer Terms dated November 30, 2023, by and between the Registrant and Sandra G. Stoneman (Filed With SEC on March 28, 2024)
- Amendment No. 1 to Executive Employment Agreement dated December 1, 2023, by and between the Registrant and Clay B. Siegall, Ph.D (Filed With SEC on March 28, 2024)
- Consulting Agreement by and between the Company and Corleen Roche, effective as of January 2, 2024, as supplemented by Task Order #1 (Filed With SEC on December 29, 2023)
- Separation Agreement by and between the Company and Corleen Roche, dated December 22, 2023 (Filed With SEC on December 29, 2023)
- Third Amended and Restated Non-Employee Director Compensation Policy, effective October 27, 2023 (Filed With SEC on November 9, 2023)
- 2020 Immunome, Inc. Equity Incentive Plan, as amended (Filed With SEC on November 9, 2023)
- Forms of Restricted Stock Purchase Agreement, Stock Option Agreement and Early Exercise Stock Purchase Agreement under the Morphimmune, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 8, 2023)
- Morphimmune, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 8, 2023)
- Employment Agreement, dated June 28, 2023, by and between Immunome, Inc. and Clay B. Siegall, Ph.D (Filed With SEC on June 29, 2023)
- Amended and Restated Employment Agreement of Matthew Robinson effective June 16, 2022 (Filed With SEC on March 16, 2023)
- Employment Agreement between the Company and Dennis Giesing effective April 7, 2021 (Filed With SEC on March 16, 2023)
- Second Amended and Restated Non-Employee Director Compensation Policy, effective as of June 15, 2022 (Filed With SEC on August 5, 2022)
- Immunome, Inc. Annual Employee Bonus Plan (Filed With SEC on March 28, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 15, 2021)
- Second Amended and Restated Employment Agreement, dated August 1, 2021, by and between the Company and Dr. Morin (Filed With SEC on August 5, 2021)
- Employment Letter Agreement between the Company and Corleen M. Roche (Filed With SEC on April 20, 2021)
- Employment Agreement between the Company and Sandra G. Stoneman effective October 19, 2020 (Filed With SEC on March 25, 2021)
- Separation Agreement and General Release between the Company and Richard Fitzgerald, dated December 1, 2020 (Filed With SEC on December 4, 2020)
- Amended and Restated Employment Agreement by and between the registrant and Michael J. Morin, dated September 23, 2020 (Filed With SEC on September 24, 2020)
- Amended and Restated Employment Agreement by and between the registrant and Purnanand D. Sarma, dated September 23, 2020 (Filed With SEC on September 24, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on September 24, 2020)
- Forms of Stock Option Grant Notice, Option Agreement, RSU Award Grant Notice and Notice of Exercise for the 2020 Equity Incentive Plan (Filed With SEC on September 24, 2020)
- 2020 Equity Incentive Plan (Filed With SEC on September 24, 2020)
